BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers.

Saved in:
Bibliographic Details
Title: BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers.
Authors: Coussy F; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France.; Medical Oncology Department, Institut Curie, PSL Research University, 75005 Paris, France.; Genetics Department, Institut Curie, PSL Research University, 75005 Paris, France., El-Botty R; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France., Château-Joubert S; BioPôle Alfort, Ecole Nationale Vétérinaire d'Alfort, 94704 Maisons Alfort, France., Dahmani A; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France., Montaudon E; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France., Leboucher S; Institut Curie, PSL Research University, UMR3306, 91405 Orsay, France., Morisset L; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France., Painsec P; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France., Sourd L; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France., Huguet L; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France., Nemati F; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France., Servely JL; BioPôle Alfort, Ecole Nationale Vétérinaire d'Alfort, 94704 Maisons Alfort, France.; INRA, PHASE Department, 37380 Nouzilly, France., Larcher T; INRA, APEX-PAnTher, Oniris, 44300 Nantes, France., Vacher S; Genetics Department, Institut Curie, PSL Research University, 75005 Paris, France., Briaux A; Genetics Department, Institut Curie, PSL Research University, 75005 Paris, France., Reyes C; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France., La Rosa P; INSERM, U900, 75005 Paris, France.; Institut Curie, PSL Research University, 75005 Paris, France., Lucotte G; INSERM, U900, 75005 Paris, France.; Institut Curie, PSL Research University, 75005 Paris, France., Popova T; Institut Curie, PSL Research University, 75005 Paris, France.; INSERM U830, 75005 Paris, France., Foidart P; Laboratory of Tumor and Developmental Biology, Groupe Interdisciplinaire de Génoprotéomique Appliqué-Cancer (GIGA-Cancer), University of Liège, Liège 4000, Belgium., Sounni NE; Laboratory of Tumor and Developmental Biology, Groupe Interdisciplinaire de Génoprotéomique Appliqué-Cancer (GIGA-Cancer), University of Liège, Liège 4000, Belgium., Noel A; Laboratory of Tumor and Developmental Biology, Groupe Interdisciplinaire de Génoprotéomique Appliqué-Cancer (GIGA-Cancer), University of Liège, Liège 4000, Belgium., Decaudin D; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France.; Medical Oncology Department, Institut Curie, PSL Research University, 75005 Paris, France., Fuhrmann L; Department of Pathology, Institut Curie, PSL Research University, 75005 Paris, France., Salomon A; Department of Pathology, Institut Curie, PSL Research University, 75005 Paris, France., Reyal F; Surgery Department, Institut Curie, PSL Research University, 75005 Paris, France.; U932, Immunity and Cancer, INSERM, Institut Curie, 75005 Paris, France., Mueller C; Queen's Cancer Research Institute, Queen's University, Kingston, ON K7L 3N6, Canada., Ter Brugge P; Division of Molecular Pathology and Cancer Genomics Centre Netherlands, Netherlands Cancer Institute, Amsterdam, 1066 CX, Netherlands., Jonkers J; Division of Molecular Pathology and Cancer Genomics Centre Netherlands, Netherlands Cancer Institute, Amsterdam, 1066 CX, Netherlands., Poupon MF; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France., Stern MH; Institut Curie, PSL Research University, 75005 Paris, France.; INSERM U830, 75005 Paris, France., Bièche I; Genetics Department, Institut Curie, PSL Research University, 75005 Paris, France., Pommier Y; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. elisabetta.marangoni@curie.fr pommier@nih.gov., Marangoni E; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France. elisabetta.marangoni@curie.fr pommier@nih.gov.
Source: Science translational medicine [Sci Transl Med] 2020 Feb 19; Vol. 12 (531).
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1946-6242
DOI:10.1126/scitranslmed.aax2625